Aspire Biopharma Holdings, Inc. (ASBP) vs CASI Pharmaceuticals Inc. (CASIF)
Aspire Biopharma Holdings, Inc. and CASI Pharmaceuticals Inc. are both Biotechnology companies. Aspire Biopharma Holdings, Inc. and CASI Pharmaceuticals Inc. are of similar size ($12.4M and $12.2M). CASI Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; Aspire Biopharma Holdings, Inc. trades at 0.2×. CASI Pharmaceuticals Inc. has the higher net margin (−232.0% vs −11,309.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, CASI Pharmaceuticals Inc. leads on 10 and Aspire Biopharma Holdings, Inc. on 4.
Valuation
Profitability
| Metric | ASBP | CASIF | Biotechnology median |
|---|---|---|---|
| Gross margin | (24.97%) | 48.65% | 65.16% |
| Operating margin | (7,491.61%) | (206.87%) | 0.00% |
| Net margin | (11,309.31%) | (232.03%) | 0.00% |
| Free cash flow margin | (7,355.07%) | (432.54%) | 0.00% |
| Return on equity | (1,032.15%) | 0.00% | (57.72%) |
| Return on assets | (152.09%) | 0.00% | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack